Back to results
US 2023/0143583 A1Published application
Amide compounds as kinase inhibitors, compositions and methods of treatment
AssigneeTranslational Drug Development, LLC
InventorsTong Wang, Stephen Gately
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to certain amides and heterocyclic compounds and uses of these amides and heterocyclic compounds to inhibit Rho-associated protein kinases and treat diseases including autoimmune disorders, graft versus host disease (GVHD), inflammation, cardiovascular disorders, central nervous system disorders, and neoplastic disorders.
Claims22
1-20. (canceled)
A compound of Formula (I):
- wherein:
- Z1 is pyrazole optionally substituted with one or more of the following:
- halo, —OH, —CN, —COOR′, —OR′, —SR′, —OC(O)R′, —NHR′, —NR′R″, —NHC(O)R′, —NHC(O)NR′R″, —C(O)NR′R″, —NS(O)2R′, —S(O)2NR′R″, —S(O)2R′, guanidino, nitro, nitroso, —C1-C6 alkyl, aryl, or —C3-C7 cycloalkyl;
- Z2 is phenyl, pyridine, or pyrazole, wherein the phenyl, pyridine, or pyrazole is optionally substituted with, H, halo, —OH, —CN, —COOR′, —OR′, —OR′OR″, —O(CH2)2NR′R″, —SR′, —OC(O)R′, —NHR′, —NR′R″, —NHC(O)R′, —NHC(O)NR′R″, —C(O)NR′R″, —NS(O)2R′, —S(O)2NR′R″, —S(O)2R′, guanidino, nitro, nitroso, —C1-C6 alkyl, aryl, —C3-C7 cycloalkyl, or a 3- to 10-membered heterocycle, and wherein the —C1-C6 alkyl, aryl, —C3-C7 cycloalkyl, or 3- to 10-membered heterocycle is optionally substituted with one or more of the following:
- halo, —OH, —CN, —COOR′, —OR′, —SR′, —OC(O)R′, —NHR′, —NR′R″, —NHC(O)R′, —NHC(O)NR′R″, —C(O)NR′R″, —NS(O)2R′, —S(O)2NR′R″, —S(O)2R′, guanidino, nitro, nitroso, —C1-C6 alkyl, aryl, or —C3-C7 cycloalkyl, and wherein the R′ or R″ are independently —H, methyl or ethyl;
- R1 is H, —C1-C6 alkyl or —C3-C7 cycloalkyl, wherein the —C1-C6 alkyl or —C3-C7 cycloalkyl is optionally substituted with one or more of the following:
- halo, —OH, —CN, —COOR′, —OR′, —SR′, —OC(O)R′, —NHR′, —NR′R″, —NHC(O)R′, —NHC(O)NR′R″, —C(O)NR′R″, —NS(O)2R′, —S(O)2NR′R″, or —S(O)2R′;
- R is methyl;
- X is a bond or —OR4, wherein R4 is H, —C1-C6 alkyl or —C3-C7 cycloalkyl;
- R2 and R3 are independently H, —C1-C6 alkyl, —C3-C7 cycloalkyl, aryl, C5-C10 membered heterocycle,
- wherein
- the —C1-C6 alkyl, —C3-C7 cycloalkyl, aryl, C5-C10 membered heterocycle is optionally substituted with halo, —OH, —CN, —COOR′, —OR′, —SR′, —OC(O)R′, —NHR′, —NR′R″, —CNR′R″, —NHC(O)R′, —NHC(O)NR′R″, —C(O)NR′R″, —NS(O)2R′, —S(O)2NR′R″, —S(O)2R′, guanidino, nitro, nitroso, —C1-C6 alkyl, aryl, —C3-C7 cycloalkyl, or 3- to 11-membered heterocycle, wherein
- the —C1-C6 alkyl, aryl, —C3-C7 cycloalkyl, or 3- to 11-membered heterocycle is optionally substituted with one or more of the following:
- halo, —OH, —CN, —COOR′, —CH2NR′R″, —OR′, —OR′R″, —SR′, —OC(O)R′, —NHR′, —NR′R″, —NHC(O)R′, —NHC(O)NR′R″, —C(O)NR′R″, —NS(O)2R′, —S(O)2NR′R″, —S(O)2R′, guanidino, nitro, nitroso, —C1-C6 alkyl, aryl, —C3-C7 cycloalkyl, and wherein
- R5 is —C1-C6 alkyl, —OCH2CH2—, —NR6CH2CH2—, —NC(O)CH2CH2—;
- R6 is H, —C1-C6 alkyl or —C3-C7 cycloalkyl;
- and
- R′ or R″ is independently —H or —C1-C6 alkyl, or R′ and R″ together, optionally attaching to N or O atom, form a 4- to 8-membered cyclic structure.
15 more elements
Dependencies are inferred from the claim text.